Tennessee Bills

including subjects Drugs

Bill Title Introduced Latest Action↑
SB 791 (110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, revises categories of patients who qualify to receive certain prescriptions of forms of buprenorphine. - Amends TCA Title 53, Chapter 11, Part 3.
Feb 08 2017 Passed On Second Consideration, Refer To Senate Health And Welfare Committee
Feb 13 2017
SB 1181 (110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, extends, from 10 to 15 days, the time period within which the owner or legal possessor of misbranded or adulterated legend drugs or devices must request a hearing to show the board of pharmacy why the drugs or devices should not be destroyed. - Amends TCA Title 39; Title 53 and Title 63.
Feb 09 2017 Assigned To S/C Health Subcommittee
Feb 17 2017
SB 1423 (110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, requires certain drug manufacturers to submit information to the department of health about drug prices; requires the department of commerce and insurance to promulgate rules relating to disclosure of drug formulary prices. - Amends TCA Title 8; Title 53; Title 56; Title 63; Title 68 and Title 71.
Feb 09 2017 Assigned To S/C Insurance And Banking Subcommittee
Feb 17 2017
HB 1328 (110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, enacts the Prescription Drug Fair Pricing Act; requires studies and reports on or before January 15, 2018, by the commissioner of health concerning price gouging for essential generic drugs and the commissioner of commerce and insurance concerning price transparency for prescription drugs; requires reports to legislative committees. - Amends TCA Title 4; Title 53; Title 56; Title 63; Title 68 and Title 71.
Feb 09 2017 Assigned To S/C Insurance And Banking Subcommittee
Feb 17 2017
HB 1054 (110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, extends, from 10 to 15 days, the time period within which the owner or legal possessor of misbranded or adulterated legend drugs or devices must request a hearing to show the board of pharmacy why the drugs or devices should not be destroyed. - Amends TCA Title 39; Title 53 and Title 63.
Feb 09 2017 Assigned To S/C Health Subcommittee
Feb 17 2017
HB 1327 (110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, requires certain drug manufacturers to submit information to the department of health about drug prices; requires the department of commerce and insurance to promulgate rules relating to disclosure of drug formulary prices. - Amends TCA Title 8; Title 53; Title 56; Title 63; Title 68 and Title 71.
Feb 09 2017 Assigned To S/C Insurance And Banking Subcommittee
Feb 17 2017
SB 1420 (110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, enacts the Prescription Drug Fair Pricing Act; requires studies and reports on or before January 15, 2018, by the commissioner of health concerning price gouging for essential generic drugs and the commissioner of commerce and insurance concerning price transparency for prescription drugs; requires reports to legislative committees. - Amends TCA Title 4; Title 53; Title 56; Title 63; Title 68 and Title 71.
Feb 09 2017 Assigned To S/C Insurance And Banking Subcommittee
Feb 17 2017
HB 861 (110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, requires, by July 1, 2017, the commissioner of health to report to the health committee of the house of representatives and the health and welfare committee of the senate the results of consultations with stakeholders and to identify what method was chosen as the best means to obtain the records to facilitate investigations and inquiries concerning opioid drug abuse, overdoses, and death. - Amends TCA Title 4; Title 33; Title 38; Title 39; Title 53; Title 63 and Title 68.
Feb 08 2017 Sponsor(S) Added.
Mar 13 2017
SB 718 (110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, requires, by July 1, 2017, the commissioner of health to report to the health committee of the house of representatives and the health and welfare committee of the senate the results of consultations with stakeholders and to identify what method was chosen as the best means to obtain the records to facilitate investigations and inquiries concerning opioid drug abuse, overdoses, and death. - Amends TCA Title 4; Title 33; Title 38; Title 39; Title 53; Title 63 and Title 68.
Feb 08 2017 Sponsor(S) Added.
Mar 13 2017
SB 991 (110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, prohibits a health insurance entity from taking certain actions with respect to coverage of prescription drugs outside of open enrollment periods. - Amends TCA Title 56.
Feb 09 2017 Taken Off Notice For Cal In S/C Insurance And Banking Subcommittee Of Insurance And Banking Committee
Apr 05 2017
HB 960 (110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, prohibits a health insurance entity from taking certain actions with respect to coverage of prescription drugs outside of open enrollment periods. - Amends TCA Title 56.
Feb 09 2017 Taken Off Notice For Cal In S/C Insurance And Banking Subcommittee Of Insurance And Banking Committee
Apr 05 2017
HB 830 (110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, enacts the "Medical Cannabis Access Act." - Amends TCA Title 4, Chapter 29; Title 4, Chapter 3, Part 2; Title 39; Title 43; Title 53, Chapter 11; Title 63 and Title 68.
Feb 08 2017 Taken Off Notice For Cal In S/C Criminal Justice Subcommittee Of Criminal Justice Committee
Apr 11 2017
SB 1119 (110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, enacts the "Medical Cannabis Access Act." - Amends TCA Title 4, Chapter 29; Title 4, Chapter 3, Part 2; Title 39; Title 43; Title 53, Chapter 11; Title 63 and Title 68.
Feb 08 2017 Taken Off Notice For Cal In S/C Criminal Justice Subcommittee Of Criminal Justice Committee
Apr 11 2017
HB 694 (110th Regular Session (2017-2018))
Drugs, Synthetic or Analogue - As enacted, excludes from the definition of marijuana a cannabidiol product approved as a prescription medication by the United States Food and Drug Administration. - Amends TCA Section 39-17-402.
Feb 02 2017 Effective Date(S) 04/12/2017
Apr 19 2017
SB 385 (110th Regular Session (2017-2018))
Drugs, Synthetic or Analogue - As enacted, excludes from the definition of marijuana a cannabidiol product approved as a prescription medication by the United States Food and Drug Administration. - Amends TCA Section 39-17-402.
Feb 02 2017 Comp. Became Pub. Ch. 120
Apr 19 2017
SB 709 (110th Regular Session (2017-2018))
Drugs, Prescription - As enacted, requires the commissioners of health and mental health and substance abuse services to produce guidelines on nonresidential buprenorphine treatment by January 1, 2018, and to annually update those guidelines. - Amends TCA Title 63, Chapter 1.
Feb 08 2017 Comp. Became Pub. Ch. 112
Apr 19 2017
HB 746 (110th Regular Session (2017-2018))
Drugs, Prescription - As enacted, requires the commissioners of health and mental health and substance abuse services to produce guidelines on nonresidential buprenorphine treatment by January 1, 2018, and to annually update those guidelines. - Amends TCA Title 63, Chapter 1.
Feb 08 2017 Effective Date(S) 04/07/2017
Apr 19 2017
HB 1148 (110th Regular Session (2017-2018))
Drugs, Prescription - As enacted, specifies that any person licensed by the board of pharmacy and holding a valid wholesaler license will be considered to be licensed as a drug distributor until such a time when the board can promulgate rules to implement the third-party logistic provider (3PL) licensing process. - Amends TCA Title 63.
Feb 01 2017 Effective Date(S) 05/04/2017
May 11 2017
SB 268 (110th Regular Session (2017-2018))
Drugs, Prescription - As enacted, specifies that any person licensed by the board of pharmacy and holding a valid wholesaler license will be considered to be licensed as a drug distributor until such a time when the board can promulgate rules to implement the third-party logistic provider (3PL) licensing process. - Amends TCA Title 63.
Feb 01 2017 Comp. Became Pub. Ch. 268
May 11 2017
SB 458 (110th Regular Session (2017-2018))
Drugs, Prescription - As enacted, authorizes local education agencies and nonpublic schools to maintain opioid antagonists in schools. - Amends TCA Title 49 and Title 63.
Feb 06 2017 Comp. Became Pub. Ch. 256
May 11 2017

Showing 1 to 20 of 86 bills